Phase IV contract offered in FDA proposal as alternative to civil money penalties.
This article was originally published in The Tan Sheet
Executive Summary
PHASE IV CONTRACT OFFERED BY FDA AS ALTERNATIVE TO CIVIL MONEY PENALTIES was floated on Capitol Hill the week of June 30. The draft proposal developed by FDA and its supporters would make drug sponsors that fail to comply with Phase IV post-marketing obligations subject to a court order to meet their commitments. Sen. Edward Kennedy (D-Mass.) has been pushing for post-marketing enforcement to be included in the FDA reform bill (S 830), but his civil money penalty proposal was defeated in mark-up by the Labor & Human Resources Committee. FDA presented its proposal in recent meetings with industry, patient groups and congressional staff.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning